<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1148383</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Cell lipid biology in infections: an overview</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Prado</surname>
<given-names>Luan Gavi&#xe3;o</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1931525"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Camara</surname>
<given-names>Niels Olsen Saraiva</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/174754"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Barbosa</surname>
<given-names>Angela Silva</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/31251"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laborat&#xf3;rio de Bacteriologia, Instituto Butantan</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Departamento de Microbiologia, Instituto de Ci&#xea;ncias Biom&#xe9;dicas, Universidade de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Laborat&#xf3;rio de Imunobiologia de Transplantes, Departamento de Imunologia, Instituto de Ci&#xea;ncias Biom&#xe9;dicas, Universidade de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Disciplina de Nefrologia, Departamento de Medicina, Universidade Federal de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Khushboo Borah Slater, University of Surrey, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Filipe Pereira-Dutra, Oswaldo Cruz Foundation (Fiocruz), Brazil</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Angela Silva Barbosa, <email xlink:href="mailto:angela.barbosa@butantan.gov.br">angela.barbosa@butantan.gov.br</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1148383</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>01</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Prado, Camara and Barbosa</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Prado, Camara and Barbosa</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Lipids are a big family of molecules with a vast number of functions in the cell membranes, within the cytoplasm, and extracellularly. Lipid droplets (LDs) are the most common storage organelles and are present in almost every tissue type in the body. They also have structural functions serving as building blocks of cellular membranes and may be precursors of other molecules such as hormones, and lipoproteins, and as messengers in signal transduction. Fatty acids (FAs), such as sterol esters and triacylglycerols, are stored in LDs and are used in &#x3b2;-oxidation as fuel for tricarboxylic acid cycle (TCA) and adenosine triphosphate (ATP) generation. FA uptake and entrance in the cytoplasm are mediated by membrane receptors. After a cytoplasmic round of &#x3b1;- and &#x3b2;-oxidation, FAs are guided into the mitochondrial matrix by the L-carnitine shuttle system, where they are fully metabolized, and enter the TCA cycle. Pathogen infections may lead to impaired lipid metabolism, usage of membrane phospholipids, and LD accumulation in the cytoplasm of infected cells. Otherwise, bacterial pathogens may use lipid metabolism as a carbon source, thus altering the reactions and leading to cellular and organelles malfunctioning. This review aims to describe cellular lipid metabolism and alterations that occur upon infections.</p>
</abstract>
<kwd-group>
<kwd> lipid</kwd>
<kwd>lipid metabolism</kwd>
<kwd>phospholipids</kwd>
<kwd>lipid droplets</kwd>
<kwd>bacterial and viral infections</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="130"/>
<page-count count="10"/>
<word-count count="5851"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Lipids are usually used as energy-storage depots, structural building blocks, and as second messengers in signaling cascades. They accumulate in lipid-storage specialized tissues, such as the adipose one, but are present in almost every cell type due to their importance as energy and carbon skeleton sources, and as hormone precursors. Through &#x3b2;-oxidation, a process in which a series of enzymes oxidize long, medium, or short FAs, cells yield much more ATP than using glucose or glycogen as primary sources. High energy-demanding cells, such as tubular epithelial cells, colonocytes, and myocytes, often use this energy pathway as their main metabolic pathway. Perturbation on lipid metabolism and its enzymes, as well as dietary overload and obesity, lead to cytoplasmic lipid accumulation and, consequently, lipotoxicity (<xref ref-type="bibr" rid="B3">Kang et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B2">Adeva-Andany et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B1">Cockcroft, 2021</xref>).</p>
<p>In general, lipids are a very diverse group of molecules, but with one characteristic in common: insolubility in water. Storage lipids are often fats, and their derivatives are FAs. They are composed of hydrocarbons, with a carbon skeleton, and may be branched or not. Unsaturation is characterized by a double bond between two carbon atoms, in a <italic>cis</italic> or <italic>trans</italic> configuration. Oxidation of FAs is a very exergonic reaction, thus producing a lot of energy that is converted into ATP in the mitochondrion (<xref ref-type="bibr" rid="B1">Cockcroft, 2021</xref>).</p>
<p>FAs uptake is mediated by three main transporters, CD36 or fatty acid translocase (FAT), fatty acid binding protein (FABP), and fatty acid transport protein (FATP). After the entrance into the cell cytoplasm, very long- and long-chain FAs are initially &#x3b1;- and &#x3b2;-oxidized in peroxisomes, and their metabolites, together with medium-chain FAs enter mitochondria through the L-carnitine shuttle system to start a new round of &#x3b2;-oxidation. At the end, acetyl-CoA is generated and enters the TCA cycle (<xref ref-type="bibr" rid="B10">Mannaerts et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B8">Luiken et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B9">Jansen and Wanders, 2006</xref>; <xref ref-type="bibr" rid="B4">Storch and McDermott, 2009</xref>; <xref ref-type="bibr" rid="B5">Schwenk et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B6">Anderson and Stahl, 2013</xref>; <xref ref-type="bibr" rid="B7">Melton et&#xa0;al., 2013</xref>).</p>
<p>Phospholipids are the major components of biological membranes and are composed of two hydrophobic fatty acyl chains and one hydrophilic head group. The fatty acyl chains are responsible for biological and physical properties affecting all biological processes that occur in the inner and outer membrane leaflets. Alterations in the fatty acyl chains are orchestrated by reacylation and deacylation, known as the Land&#x2019;s cycle (<xref ref-type="bibr" rid="B12">Van Meer et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B11">Wang and Tontonoz, 2019</xref>; <xref ref-type="bibr" rid="B1">Cockcroft, 2021</xref>). Perturbance of phospholipid content in the cell membrane may be involved in the pathogenesis of some diseases, including bacterial infections.</p>
<p>Intracellular pathogens have well-defined mechanisms to exploit the host&#x2019;s cell lipid metabolism and use those molecules as an energy source for their metabolic processes. In extracellular pathogens, lipid metabolism impairment and metabolism exploitation are still not completely elucidated (<xref ref-type="bibr" rid="B13">Walpole et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B14">Libbing et&#xa0;al., 2019</xref>).</p>
<p>Besides lipids&#x2019; roles in disease pathogenesis, there is a crescent body of information outlining lipid droplets (LDs) as a hub that integrates metabolic and inflammatory responses to face infections (<xref ref-type="bibr" rid="B15">Monson et&#xa0;al., 2021b</xref>). In viral infections, LDs are used as the site of viral replication, since it is partially protected against the machinery of pathogen killing. They also use the lipid content from LDs to build up their capsids (<xref ref-type="bibr" rid="B17">Samsa et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B16">van der Meer-Janssen et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B18">Far&#xed;as et&#xa0;al., 2022</xref>). Furthermore, foamy macrophages, a hallmark of tuberculous lesions, are generated after <italic>Mycobacterium</italic> species induction of LDs formation (<xref ref-type="bibr" rid="B19">Agarwal et&#xa0;al., 2021</xref>).</p>
<p>This review aims to describe lipid metabolism and exploitation of lipids, lipid metabolism, and cell membrane phospholipids by pathogens, as well as their consequences to cells and organisms.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Lipid metabolism</title>
<p>Lipids are molecules composed of a hydrocarbon chain, branched or not, with a carboxyl-terminal group. As mentioned above, unsaturated FAs have a double bond between two carbons in the <italic>cis</italic> or <italic>trans</italic> position. Saturated FAs have linear chains with no double bonds along them, that may be as small as those with two carbons (acetic acid) or as large as those with 26 carbons (cerotate) (<xref ref-type="bibr" rid="B2">Adeva-Andany et&#xa0;al., 2019</xref>).</p>
<p>Lipid metabolism is a very complex process that involves both anabolic and catabolic reactions. The process starts with FA degradation and absorption by the gastrointestinal tract and the interaction of lipids with the gut microbiome. As this particular subject is beyond the scope of this review, the interested reader may search for additional information, well provided by <xref ref-type="bibr" rid="B21">Schoeler and Caesar (2019)</xref>, who extensively discuss this aspect of lipid metabolism. Here we will focus on intracellular lipid metabolism and its importance for maintenance of the cellular functioning.</p>
<p>CD36, also known as fatty acid translocase, is a receptor of the scavenger receptor family that mediates the uptake of FAs from the extra- to the intracellular milieu (<xref ref-type="bibr" rid="B8">Luiken et&#xa0;al., 2002</xref>; <xref ref-type="bibr" rid="B24">Pepino et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B25">Hou et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B23">Hua et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Yang et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B22">Jay and Hamilton, 2018</xref>). It is an integral membrane protein, highly glycosylated, and present in erythrocytes, platelets, immune cells, adipocytes, enterocytes, and epithelial cells (<xref ref-type="bibr" rid="B24">Pepino et&#xa0;al., 2014</xref>). Although it has a well-described function as a FA transporter, CD36 is also involved in the recognition of other molecules, such as thrombospondin, collagen, <italic>Plasmodium</italic>-infected erythrocytes, and oxidized-LDL (<xref ref-type="bibr" rid="B29">Nicholson et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B30">Silverstein and Febbraio, 2010</xref>; <xref ref-type="bibr" rid="B22">Jay and Hamilton, 2018</xref>; <xref ref-type="bibr" rid="B27">Mar&#xe9;chal et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B28">Pombinho et&#xa0;al., 2018</xref>).</p>
<p>It is known that CD36 production is augmented during acute and chronic kidney diseases, which is associated with epithelial-to-mesenchymal transition (EMT) and inflammation in animal and cellular models of kidney injury (<xref ref-type="bibr" rid="B25">Hou et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B23">Hua et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B26">Yang et&#xa0;al., 2017</xref>). Endothelial cells are also prone to undergo endothelial-to-mesenchymal transition after infection or disturbance of cell functioning. In primary endothelial cells infected by <italic>Leptospira interrogans</italic> CD36 is overexpressed in the cell membrane, as evidenced by immunofluorescence microscopy (<xref ref-type="bibr" rid="B31">Sato and Coburn, 2017</xref>).</p>
<p>Treatment of bovine mammary epithelial cells with palmitate leads to CD36 gene overexpression, in a dose-dependent manner. Cells treated with as much as 600 &#xb5;M of palmitate have CD36 gene expression augmented at almost 40-fold compared to those without any treatment, which highlights the importance of this receptor in lipid uptake, and how lipid intake may influence its concentration in the cell membrane (<xref ref-type="bibr" rid="B32">Qi et&#xa0;al., 2014</xref>).</p>
<p>Other receptors are involved in lipid uptake to the cytoplasm, such as fatty acid transporter proteins 1 to 6 (FATP 1-6) and fatty acids binding proteins (FABPs) (<xref ref-type="bibr" rid="B7">Melton et&#xa0;al., 2013</xref>). FATPs are also integral membranes with different roles, according to each type. Collectively they are described as membrane-bound proteins that act in the uptake of long-chain FAs and in the activation of FAs, as the first step of &#x3b2;-oxidation, i.e., acylation, of very long-chain FAs (<xref ref-type="bibr" rid="B33">DiRusso et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B6">Anderson and Stahl, 2013</xref>; <xref ref-type="bibr" rid="B7">Melton et&#xa0;al., 2013</xref>).</p>
<p>FABPs have a high affinity to long-chain FAs and bind both saturated and unsaturated FAs (<xref ref-type="bibr" rid="B4">Storch and McDermott, 2009</xref>). There are multiple FABPs functioning similarly, and the affinity to a given FA increases as hydrophobicity rises. There are 9 different FABP types described to date, known as FABP 1-9 (<xref ref-type="bibr" rid="B35">Ono, 2005</xref>; <xref ref-type="bibr" rid="B34">Li et&#xa0;al., 2020</xref>). Different isoforms are named after the main organ where they were described (<xref ref-type="bibr" rid="B36">Furuhashi, 2019</xref>). These proteins, also characterized as chaperones, exert functions in FA transport and in intracellular communication (<xref ref-type="bibr" rid="B37">Gorbenko et&#xa0;al., 2010</xref>).</p>
<p>Besides being internalized by receptors, endocytosis is also used as a means of transporting lipids into the cell cytoplasm. The most well-studied forms of general endocytosis are the ones mediated by clathrin and caveolin (<xref ref-type="bibr" rid="B39">Johannes et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B38">Kaksonen and Roux, 2018</xref>; <xref ref-type="bibr" rid="B40">Kostarnoy et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B42">Abdulova et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B41">Liu et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B43">Tang et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B44">Yu and Yoshimura, 2023</xref>). More recently, a new mechanism of lipid transport and uptake, named Mincle-mediated endocytosis (MiMe) was described. The Mincle receptor was first reported as a pattern recognition receptor (PRR) and plays a role in triggering inflammatory responses after the recognition of fungal and bacterial lipids. However, it also mediates lipid uptake, as the knockout of Mincle leads to a pronounced decrease in lipid internalization by brain vessel endothelial cells.</p>
<p>Free FAs, or albumin-bound FAs are present in the bloodstream and enter the cells by their transporters, as described above. After their entry into the cytoplasm, FAs are activated by the enzyme fatty acyl CoA synthetase that catalyzes the binding of an Acyl-CoA to each acetyl moiety. Very long-chain FAs must be shortened by peroxisomal &#x3b1;-oxidation before entering mitochondria (<xref ref-type="bibr" rid="B2">Adeva-Andany et&#xa0;al., 2019</xref>).</p>
<p>Carnitine palmitoyl transferase 1 (CPT1) then catalyzes the transfer of acylcarnitine to the inner mitochondrial membrane. This process occurs with the acyl groups being transferred from Coenzyme A (CoA) to L-carnitine, generating the acylcarnitine esters that are allowed to pass through the mitochondrial outer membrane. Carnitine acyl-carnitine translocase (CACT) transports the acyl-carnitine esters into the mitochondrial matrix in exchange for a free carnitine. Finally, Carnitine palmitoyl transferase 2 (CPT2) catalyzes fatty acyl-CoA esters import into the mitochondria, transferring the acyl groups from the acyl-carnitine esters, generating acyl-CoA esters (<xref ref-type="bibr" rid="B2">Adeva-Andany et&#xa0;al., 2019</xref>).</p>
<p>In the mitochondrial matrix, Acyl-CoA is cleaved from FA-Acyl-CoA by &#x3b2;-oxidation and enters the TCA cycle to generate ATP (<xref ref-type="bibr" rid="B45">Berndt et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B46">Gewin, 2021</xref>). The whole &#x3b2;-oxidation process is catalyzed by only four different enzymes, e.g., Acyl-CoA dehydrogenase, Enoyl-CoA hydratase, 3-L-hydroxyacyl-CoA dehydrogenase, and &#x3b2;-ketothiolase. After the four rounds, there is generation of an acetyl-CoA that enters the TCA pathway, and an Acyl-CoA ester, with two carbons less. These iterative rounds keep happening until total Acyl-CoA esters are consumed (<xref ref-type="bibr" rid="B2">Adeva-Andany et&#xa0;al., 2019</xref>).</p>
<p>Conversely, acetyl-CoAs that are produced in the mitochondria and are not used in TCA are exported to the cytosol, and back to the ER, where they are used in lipogenesis, contributing to the biosynthesis of neutral lipids and phospholipids (<xref ref-type="bibr" rid="B48">W&#xe4;ltermann et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B49">Turchetto-Zolet et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B47">Hsu et&#xa0;al., 2023</xref>) <italic>De novo</italic> lipid synthesis or lipid biogenesis is governed by the mTORC1 signaling pathway (<xref ref-type="bibr" rid="B51">D&#xfc;vel et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B55">Li et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B52">Peterson et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B50">Owen et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B54">Han et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B53">Lee et&#xa0;al., 2017</xref>), which is responsible for lipogenic enzyme production by SREBP 1 and 2 induction or reduction of their inhibitors (<xref ref-type="bibr" rid="B51">D&#xfc;vel et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B55">Li et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B52">Peterson et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B50">Owen et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B54">Han et&#xa0;al., 2015</xref>). Another important role of the mTORC pathway is mediated by SRKP2 that induces more efficient mRNA splicing of lipogenic enzymes, thus enhancing <italic>de novo</italic> lipid synthesis (<xref ref-type="bibr" rid="B53">Lee et&#xa0;al., 2017</xref>).</p>
<p>In this way, lipids are produced after the generation of Acetyl-CoA, in the TCA cycle, from either citrate or acetate by ATP citrate lyase (ACLY) or acyl-CoA synthetase short-chain (ACSS). Fatty acid synthesis then takes place by using Acetyl-CoA and Malonyl-CoA, catalyzed by Fatty Acid Synthetase. The addition of more acetyl-CoA will lead to the formation of a palmitate molecule which is then used to generate longer FAs by elongation processes, unsaturated FAs catalyzed by stearoyl-CoA desnaturase 1 (SCD1), and finally phospholipids and signaling lipids (<xref ref-type="bibr" rid="B53">Lee et&#xa0;al., 2017</xref>). Although produced in the mitochondria, the cytosolic acetyl-CoA pool is used by lipogenic enzymes for FA biosynthesis. <italic>In vitro</italic>, cells under glucose restriction use more acetyl-L-carnitine to generate acetyl-CoA and consequently, fatty acids. Therefore, L-carnitine not only participates in the L-carnitine shuttle but also represents a carbon source to cells under physiological or hypoglycemic environment (<xref ref-type="bibr" rid="B47">Hsu et&#xa0;al., 2023</xref>).</p>
<p>Other important mechanism involved in cell homeostasis and pathogen response is macroautophagy, or simply autophagy. During this process, cells engulf and destroy organelles to maintain proper functioning. The phagophore, a double-membrane vacuole, is responsible for engulfing the organelles and fusing them with lysosomes where hydrolysis occurs. The formation of the phagophore is mediated by membrane donation from healthy organelles, but also by <italic>de novo</italic> synthesis of FAs in the ER, catalyzed by long-chain Acyl-CoA synthetase (ACS), in particular by the enzyme Faa1 (<xref ref-type="bibr" rid="B56">Sch&#xfc;tter et&#xa0;al., 2020</xref>).</p>
<p>Triacylglycerol, a glycerolipid, is used as storage and is composed of three FAs attached to the three hydroxyl groups of the glycerol backbone (<xref ref-type="bibr" rid="B1">Cockcroft, 2021</xref>). Cell membranes are composed of three main lipids: glycerophospholipids, sphingolipids, and sterols, such as cholesterol. Mammalian cells synthesize and yield phospholipids that are not present in prokaryotes, such as phosphatidylserine, phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine, and phosphatidylglycerol. The percentage of each molecule varies according to the cell type and environment (<xref ref-type="bibr" rid="B11">Wang and Tontonoz, 2019</xref>; <xref ref-type="bibr" rid="B1">Cockcroft, 2021</xref>).</p>
<p>Neutral lipids are synthesized in the ER mainly as triacylglycerol and are stored in LDs. The most important enzymes, that are rate limiting in the synthesis of triacylglycerol, are acyl-CoA diacylglycerol acyltransferase (DGAT) 1 and 2, responsible for catalyzing the acylation of sn-1,2-diacylglycerol, using acetyl-CoA as a substrate. Evolutionary studies have shown that these enzymes are conserved in all eukaryotes, despite molecular and genetic differences (<xref ref-type="bibr" rid="B49">Turchetto-Zolet et&#xa0;al., 2011</xref>). Inhibition of DGAT 1 and 2 leads to decreased LD formation, and to impaired viral replication and bacterial survival during infections (<xref ref-type="bibr" rid="B58">Monson et&#xa0;al., 2021a</xref>; <xref ref-type="bibr" rid="B60">Yuan et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B57">Kiarely Souza et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B59">Dias et&#xa0;al., 2023</xref>).</p>
<p>Membrane phospholipid synthesis occurs in the ER. Phosphatidic acid (PA) is used as the precursor of most of the other phospholipids in the host&#x2019;s cells. A two-round acylation of glycerol-3-phosphate is mediated by the enzymes Glycerol-3-Phosphate Acyltransferase (GPAT) and Lyso-PA Acyltransferase (LPAAT), with PA as an end product. From PA, other phospholipids, such as phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine are produced. Phosphatidylglycerol and cardiolipin are synthesized in the mitochondria. After their synthesis, phospholipids are addressed to the cytoplasmic and other membranes in the cell and are integrated into them (<xref ref-type="bibr" rid="B12">Van Meer et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B1">Cockcroft, 2021</xref>).</p>
</sec>
<sec id="s3">
<label>3</label>
<title>Lipid droplets and their roles in physiology and pathology</title>
<p>LDs are important organelles for cellular functioning and are constituted by high hydrophobic neutral FAs, within an aqueous environment. LDs are present in almost every cell in the organism and are responsible for FAs and specific protein storage, besides taking part in other complex processes, such as viral replication (<xref ref-type="bibr" rid="B61">Walther and Farese, 2012</xref>).</p>
<p>A family of proteins named perilipin (PLINs) is involved in lipid uptake, coating, and addressing LDs inside cells (<xref ref-type="bibr" rid="B62">Frank et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B63">Najt et&#xa0;al., 2022</xref>). Perilipin 1 was the first perilipin described (<xref ref-type="bibr" rid="B64">Greenberg et&#xa0;al., 1991</xref>) and after its discovery, the study of LDs, their lipidomic and proteomics, and the role of LDs in health and disease have increased dramatically, expanding the LD biology field (<xref ref-type="bibr" rid="B74">Kobayashi et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B71">Kuerschner et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B69">Garc&#xed;a-Arcos et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B49">Turchetto-Zolet et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B68">Hsieh et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B76">Lin et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B75">Markgraf et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B73">Kamili et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B77">Li et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B66">Viktorova et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B65">Freyre et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B70">Guyard et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B67">Kim et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B72">Oluwadare et&#xa0;al., 2022</xref>).</p>
<p>Assembly of LDs in the cytoplasm is thought to occur in very close proximity to the ER, but the exact mechanism by which those organelles are formed is still not completely understood. It has been shown that ER, mitochondria, and LDs are in close contact during LD formation and that this contact is mediated by two proteins called oxysterol binding protein (OSBP)-related protein (ORP) 5 and ORP8 (<xref ref-type="bibr" rid="B70">Guyard et&#xa0;al., 2022</xref>). Besides those, PLIN2 is involved in FA uptake and in addressing it in the forming LD (<xref ref-type="bibr" rid="B68">Hsieh et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B63">Najt et&#xa0;al., 2022</xref>). Other protein that may be involved in the inflammatory response and LD formation is the cell death-inducing DFF45-like effector b (Cideb). Mice lacking this protein are more prone to developing severe DSS-induced colitis and even more severe DSS-induced colitis if they undergo a high-fat diet (<xref ref-type="bibr" rid="B78">Sun et&#xa0;al., 2017</xref>). After the formation of a LD, enlargement is achieved by the fusion of multiple droplets. Besides the phospholipid monolayer, that separates LDs from the aqueous environment of the cytoplasm, there are also specific proteins attached to or in close relation with the LD&#x2019;s phospholipid monolayer (<xref ref-type="bibr" rid="B61">Walther and Farese, 2012</xref>).</p>
<p>Usage (lipolysis) or storage (lipogenesis) of lipid content from LDs are very strictly regulated. Insulin and glucagon participate in this regulation, as they are major regulators of metabolism (<xref ref-type="bibr" rid="B61">Walther and Farese, 2012</xref>). Within the cell, the mechanism of new LD formation is still under debate, but the production of triacylglycerols and sterol ester by enzymes localized in the ER and the budding of the nascent LD from the ER membrane is one of the proposed mechanisms. Otherwise, usage of lipid content from LDs is mediated by lipases, such as the Adipose Triacylglycerol Lipase (ATGL) that converts triacylglycerol to diglyceride, and the Hormone-sensitive Lipase (HSL) that breaks diglyceride into monoglyceride (<xref ref-type="bibr" rid="B61">Walther and Farese, 2012</xref>; <xref ref-type="bibr" rid="B15">Monson et&#xa0;al., 2021b</xref>). The involvement of other cellular mechanisms in lipid metabolism has been described, though yet not fully understood (<xref ref-type="bibr" rid="B81">Singh et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B80">Yan et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B79">Jarc and Petan, 2019</xref>).</p>
<p>Autophagy seems to control LD digestion and lipolysis. Inhibition of autophagy in hepatocytes by knocking down the <italic>Atg5</italic> gene leads to an augmentation of the number and size of LDs when cells are treated with oleate overload compared to cells in resting conditions. Lipid accumulation in those cells is probably mediated by autophagy inhibition, leading to impaired lipolysis (<xref ref-type="bibr" rid="B81">Singh et&#xa0;al., 2009</xref>).</p>
<p>Interferons play a specific role in the generation of LDs, especially during viral infection. Interferon-stimulated genes (ISG) encode some important proteins that act as inhibitors of LD formation (<xref ref-type="bibr" rid="B85">Helbig et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B82">Pe&#xf1;a C&#xe1;rcamo et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B84">Bosch et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B83">An et&#xa0;al., 2022</xref>). One of those proteins is the Sterile Alpha Motif and Histidine-aspartate Domain containing protein 1 (SAMHD1). In an HCV infection model, cells that overexpress this protein had 50% less LDs compared to the control and, consequently, produced less virus. On the contrary, the knockdown of the SAMHD1 led to an increase in HCV core protein detection (<xref ref-type="bibr" rid="B83">An et&#xa0;al., 2022</xref>). Other ISG that influences LD formation is Viperin. In homeostatic conditions this protein is localized in the ER and is transported to LDs. Viperin also exerts an antiviral role, during infection by Jun&#xed;n mammarenovirus (<xref ref-type="bibr" rid="B82">Pe&#xf1;a C&#xe1;rcamo et&#xa0;al., 2018</xref>).</p>
<p>LDs are also the site of eicosanoid production since they are a reservoir of arachidonic acid (<xref ref-type="bibr" rid="B86">Moreira et&#xa0;al., 2009</xref>). In Caco2 cells, the presence of cyclooxygenase-2 (COX-2) and prostaglandin E<sub>2</sub> (PGE) was described and correlated to inflammation during colon cancer (<xref ref-type="bibr" rid="B87">Accioly et&#xa0;al., 2008</xref>). In oleic acid-treated IEC-6 cells, the formation of new LDs overlaps the compartmentalization of cytosolic PLA<sub>2</sub>, with production and storage of PGE<sub>2</sub> within the LDs (<xref ref-type="bibr" rid="B86">Moreira et&#xa0;al., 2009</xref>). In the HL-60-derived neutrophils, treatment with <italic>Porphyromonas gengivalis</italic> led to an increased number of LDs, with a concomitant increase in Perilipin 3 protein. Interestingly, there is also an increase in PGE<sub>2</sub> production and release, which demonstrates that there is a relation between the production of LDs and its proteins, and the production and release of eicosanoids (<xref ref-type="bibr" rid="B88">Nose et&#xa0;al., 2013</xref>).</p>
<sec id="s3_1">
<label>3.1</label>
<title>The role of LDs in viral infection</title>
<p>Viral infection is known to induce LD accumulation in the cell cytoplasm. Both Dengue and Zika viruses were shown to induce LD accumulation in vertebrate and invertebrate hosts. Hepatitis C, Herpes simplex-1, Influenza-A, and SARS-CoV-2 also induce LDs in human and mouse models. Viruses use LDs to evade the host&#xb4;s innate immune system to replicate and form new viral particles (<xref ref-type="bibr" rid="B89">Barba et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B17">Samsa et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B90">Barletta et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B92">Episcopio et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B93">da Silva Gomes Dias et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B58">Monson et&#xa0;al., 2021a</xref>).</p>
<p>SARS-CoV-2, the agent of COVID-19, uses cells&#x2019; machinery to induce the production of triacylglycerol and, consequently, LD formation. Those are used by the virus to guarantee a high rate of virion replication. The virus nucleocapsid protein activates DGAT1 and 2 expression, and adipocyte differentiation-related protein (ADRP) is also overexpressed, leading to the formation of more LDs. DGAT inhibition by silencing RNA or pharmacologically, by xanthohumol, leads to lower yields of virus <italic>in vitro</italic> and a better response to infection <italic>in vivo</italic>, respectively (<xref ref-type="bibr" rid="B93">da Silva Gomes Dias et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B60">Yuan et&#xa0;al., 2021</xref>). Another viral protein that is involved in the accumulation of LDs during COVID-19 is ORF3a. The protein itself is capable of inducing LD accumulation by impeding autophagy flux in the cells. Mutations in the ORF3a protein, such as T223I and S171L abrogated induction of LDs and led to deficient replication and lower virus yield <italic>in vitro</italic> (<xref ref-type="bibr" rid="B95">Wang et&#xa0;al., 2023</xref>).</p>
<p>Flaviviruses, such as Zika virus and Dengue virus, are widely known to use cellular lipids to replicate and induce the host&#x2019;s inflammatory response. Zika virus induces LD formation during the early stage of infection and depletes LD storage during late-stage infection. Inhibition of autophagy in Zika virus-infected MDCK cells leads to LD content reduction and, consequently, viral replication reduction. There is also evidence that DGAT-1 blockage in neural cells and in mice reduces viral replication by blocking LD formation in those cells (<xref ref-type="bibr" rid="B97">Ambroggio et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B58">Monson et&#xa0;al., 2021a</xref>; <xref ref-type="bibr" rid="B59">Dias et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B96">Stoyanova et&#xa0;al., 2023</xref>).</p>
<p>As mentioned above, viral infection leads to transient LD induction, and type I- and III-interferon (IFN) mRNA levels are also elevated during the early stages of infection. Both LD and IFN levels increase as early as 2 hours post-infection for LDs and 8 hours post-infection for IFN, remain elevated during the next 48 hours and return to baseline at 72 hours post-infection (<xref ref-type="bibr" rid="B58">Monson et&#xa0;al., 2021a</xref>).</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Lipids and bacterial infection</title>
<p>Intracellular bacteria developed a wide range of mechanisms that allow them to invade and multiply inside the host&#x2019;s cells, such as specialized phagocytes, or other cell types including epithelial or adipose cells. Those mechanisms include avoidance of lysosome fusion to phagosomes, and the ability of those pathogens to survive and grow inside phagocytic vacuoles. After entry into cells, those pathogens rely only on the host&#x2019;s metabolism to obtain the energy necessary for survival and growth. Subversion of cell lipid metabolism, and the ability of the pathogen to use lipids from the hosts as building blocks and energy sources is one of the mechanisms that allow intracellular persistence (<xref ref-type="bibr" rid="B99">Gago et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B98">Walenna et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B13">Walpole et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B14">Libbing et&#xa0;al., 2019</xref>).</p>
<p>By exploiting the role of FABPs in controlling fat metabolism to obtain nutrients from host cells, intracellular microorganisms, such as <italic>Chlamydia pneumoniae</italic>, hijack FABP4 and induce fatty acid oxidation (FAO) to obtain ATP generated by the host cells, consequently reducing the number and size of LDs inside adipocytes and releasing high amounts of glycerol and FAs. Thus, the use of cellular FAO to fuel bacterial TCA allows replication, growth, and persistence inside the host&#x2019;s cells (<xref ref-type="bibr" rid="B98">Walenna et&#xa0;al., 2018</xref>).</p>
<p>
<italic>Salmonella Typhimurium</italic>, a facultative intracellular bacterium, induces LD biogenesis as early as 1-hour post-infection in macrophages. Differently, <italic>Escherichia coli</italic> and dead <italic>S. Typhimurium</italic> are not able to cause LD accumulation. This capacity to induce early LD accumulation is dependent on the type III secretion system and contributes to intracellular bacterial survival and proinflammatory response (<xref ref-type="bibr" rid="B57">Kiarely Souza et&#xa0;al., 2022</xref>).</p>
<p>The foamy macrophage is a hallmark of tuberculous lesions. Those are macrophages with extreme LD accumulation. Different from what was first described, IFN-&#x3b3; induces LD formation in macrophages during <italic>Mycobacterium tuberculosis</italic> infection as a host response to infection, and, surprisingly, <italic>M. tuberculosis</italic> is not able to acquire lipids from IFN-&#x3b3; induced LDs. Thus, they are not a lipid source for the bacteria inside macrophages (<xref ref-type="bibr" rid="B100">Knight et&#xa0;al., 2018</xref>). Although the use of lipids from the host&#x2019;s LD may not seem indispensable for <italic>M. tuberculosis</italic> growth, <italic>in vitro</italic> infection of macrophages by the vaccine strain bacillus Calmette-Gu&#xe9;rin induces LD formation by TLR2 and leads to PGE<sub>2</sub> production and the presence of cyclooxygenase-2 inside the LDs (<xref ref-type="bibr" rid="B101">D&#x2019;avila et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B102">Almeida et&#xa0;al., 2014</xref>). Given the participation of macrophages in the response to infection and the ability of <italic>M. tuberculosis</italic> to trigger the formation of LDs inside those cells, it has become clearer that LDs are not only used by pathogens as a carbon source but are also an innate immune response to infection (<xref ref-type="bibr" rid="B101">D&#x2019;avila et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B102">Almeida et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B103">Kumar et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B57">Kiarely Souza et&#xa0;al., 2022</xref>).</p>
<p>Since extracellular bacteria do not invade cells during infection, they evolved to exploit and use cells&#x2019; lipid storages from different locations, but also from LDs (<xref ref-type="bibr" rid="B104">Plotkowski et&#xa0;al., 2008</xref>). A brief explanation of FA transport to mitochondria, and how pathogens may interfere with lipid metabolism and cell membrane phospholipids is depicted in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Schematic illustration of lipid fate within the cell. Fatty acids (FAs) bind to their membrane receptors and are translocated to the cytoplasm mediated by the FAs transporters (CD36, FABP, and FATP), where they are chemically modified. First, fatty acyl CoA synthetase adds an acyl CoA moiety to the FA. Then, Carnitine Palmitoyl Transferase 1A (CPT1A) converts the Fatty acyl CoA to Acyl carnitine and facilitates its passage through the mitochondrial outer membrane. Acyl carnitine enters the mitochondrial matrix in exchange for one free carnitine, mediated by Carnitine Acyl Carnitine Transferase (CACT). Carnitine Palmitoyl Transferase 2 (CPTA2) converts acylcarnitine to Acyl-CoA esters that are oxidized to Acyl-CoA that enters the Tricarboxylic Acid Cycle. The increase in the amount of membrane fatty acids receptors leads to the accumulation of cytoplasmic FAs, that are stored as lipid droplets (LDs). Inhibition of the autophagic flux is also responsible for LDs cytoplasmic accumulation. Extracellular pathogens such as <italic>P. aeruginosa</italic> produce enzymes like Phospholipase A<sub>2</sub> (PLA<sub>2</sub>) that convert membrane phospholipids into Prostaglandin E<sub>2</sub> (PGE<sub>2</sub>). Also, the spirochete <italic>B</italic>. <italic>burgdorferi</italic> can incorporate membrane phospholipids into their own membrane and then, reincorporate them into the cell membrane, leading to the production of antibodies underlying autoimmune responses. Figure generated by <uri xlink:href="https://www.biorender.com/">BioRender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1148383-g001.tif"/>
</fig>
<p>Extracellular bacteria do not invade cells to escape immune responses or to obtain carbon and energy sources. However, they can exploit lipids from cell membranes. There is a growing body of evidence suggesting that extracellular pathogens are able to use host&#x2019;s membrane phospholipids as a source of FAs to assemble their cell membrane, and also degrade phospholipids leading to the production of proinflammatory cytokines (<xref ref-type="bibr" rid="B14">Libbing et&#xa0;al., 2019</xref>). Also, <italic>Helicobacter pylori</italic> can glycosylate and use the host&#x2019;s cholesterol to grow and evade the immune system (<xref ref-type="bibr" rid="B105">Wunder et&#xa0;al., 2006</xref>). Although these data point to the ability of some bacteria to use hosts&#x2019; lipids, the direct use of LDs as well as their induction or inhibition, and their role in direct cell lesions are still being investigated (<xref ref-type="bibr" rid="B105">Wunder et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B104">Plotkowski et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B106">Dulberger et&#xa0;al., 2020</xref>).</p>
<p>
<italic>Pseudomonas aeruginosa</italic> produces a phospholipase-like protease, ExoU, an effector of the type III secretion system that induces the production of eicosanoid-mediated proinflammatory cytokines in an endothelial cell line and in a murine model of infection (<xref ref-type="bibr" rid="B107">Saliba et&#xa0;al., 2005</xref>). The presence of ExoU in <italic>P. aeruginosa</italic> isolates is related to antimicrobial resistance and the occurrence of tissue necrosis (<xref ref-type="bibr" rid="B112">Sharma et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B111">Subedi et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B109">Springer et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B108">Bagayoko et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B110">Deruelle et&#xa0;al., 2021</xref>). Although related to bacterial virulence, the protease needs a host chaperone to bind to the cell membrane and to induce cell rupture and inflammation. The DNAJC5 chaperone may be one of the chaperones involved in the process since human DNAJC5-deficient cells and <italic>Drosophila</italic> flies with the DNAJC5 orthologue knocked down are resistant to the necrosis effects caused by ExoU protease (<xref ref-type="bibr" rid="B110">Deruelle et&#xa0;al., 2021</xref>). <italic>In vitro</italic> studies showed that ExoU may interact with phosphatidylinositol-containing lipids and cleave them. Since cell membranes are composed of phosphatidylinositol-containing lipids, their composition may target it to ExoU action, leading to cell membrane rupture and tissue necrosis (<xref ref-type="bibr" rid="B109">Springer et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B110">Deruelle et&#xa0;al., 2021</xref>).</p>
<p>Another important enzyme produced by <italic>P. aeruginosa</italic> and secreted by its type V secretion system is PlpD, which displays a phospholipase A<sub>1</sub> activity and has a catalytic domain that is quite similar to ExoU. PlpD is also able to bind mainly to phosphatidylinositol, but also to phosphatidic acid, phosphatidylserine, and phosphatidylglycerol (<xref ref-type="bibr" rid="B113">Da Mata Madeira et&#xa0;al., 2016</xref>). Despite the well-described binding of PlpD to phospholipids, the exact role of this enzyme in phospholipids&#x2019; cleavage is not completely understood. In contrast, a direct activity against phospholipids has been described for a PlpD homologue from <italic>Fusobacterium nucleatum</italic> (<xref ref-type="bibr" rid="B114">Trunk et&#xa0;al., 2019</xref>).</p>
<p>
<italic>Helicobacter pylori</italic> infection is associated with gastritis, gastric ulcer, and gastric cancer. As the pathogen does not have any machinery to produce cholesterol, it relies only on the host&#x2019;s cholesterol which is incorporated onto the bacterial cell membrane. <italic>H. pylori</italic> can glycosylate host cholesterol before incorporating it, and differences in glycosylation are associated with immune escape. By &#x3b1;-glycosylating cholesterol with the consequent generation of cholesteryl-&#x3b1;-glucosides they maintain themselves attached to the gastric mucosa and subvert neutrophils and macrophages action, delaying phagocytosis (<xref ref-type="bibr" rid="B105">Wunder et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B116">Du et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B117">Hsu et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B118">Qaria et&#xa0;al., 2021</xref>).</p>
<p>It has been postulated that <italic>H. pylori</italic> also excretes a vacuolating toxin, named VacA, which targets lipid rafts and sphingomyelin (SM), and is part of a whole mechanism that allows the bacterium to survive in the epithelium surface and extract nutrients from host cells, especially lipids. The association of multimeric VacA is dependent on low pH and the complex binds to the membrane as 26 nm oligomers. In supported lipid bilayers <italic>in vitro</italic>, VacA binds to SM plus cholesterol lipid bilayers without a clear lipid domain preference, but it binds to raft-like domains in lipid bilayers made of dioleoylphosphatidylcholine, SM, and cholesterol. Although it targets the above-mentioned lipids, there is a clear preference of VacA for phosphatidylserine in supported lipid bilayers, given its avidly for this phophplipid (<xref ref-type="bibr" rid="B125">Pagliaccia et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B120">Geisse et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B123">Gupta et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B121">Sewald et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B119">Gupta et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B124">Kim and Blanke, 2012</xref>; <xref ref-type="bibr" rid="B122">Raghunathan et&#xa0;al., 2018</xref>).</p>
<p>The use of host&#x2019;s cell membrane lipids by extracellular pathogens is also considered a virulence factor. <italic>Borrelia burgdorferi</italic>, the causative agent of Lyme disease, exchanges lipids from lipid rafts with HeLa cells, <italic>in vitro</italic>. After getting cholesterol from the cell membrane, those spirochetes metabolize and integrate it into their cell wall. On the other hand, as they are capable of transferring metabolized cholesterol from their cell wall to the cell membrane, they target the cell to immune system attack (<xref ref-type="bibr" rid="B126">&#xd6;stberg et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B127">Crowley et&#xa0;al., 2013</xref>).</p>
<p>The production of IgG anti-mammalian membrane phospholipids has been proposed as a diagnostic tool to follow the efficiency of Lyme disease treatment. Mice produce anti-phosphatidylglycerol, phosphatidylcholine, phosphatidic acid, phosphatidylserine, and phosphatidylethanolamine after infection by <italic>Borrelia burgdorferi</italic> cultured in a medium that contains those phospholipids. In human sera, the same pattern of IgG production against phospholipids has been described. In brief, these spirochetes are capable of incorporating host phospholipids, and this mechanism is probably related to the occurrence of symptoms related to autoimmunity, thus important to the pathogenesis of the disease (<xref ref-type="bibr" rid="B129">Arora et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B128">Gwynne et&#xa0;al., 2022</xref>).</p>
<p>Periodontal pathogens, <italic>Porphyromonas gingivalis</italic> and <italic>Fusobacterium nucleatum</italic> are phagocytosed and induce the formation of LDs within murine and human macrophage cell lines, i.e., Raw264.7 and THP-1. The proposed mechanism by which those pathogens induce LD accumulation is by disruption of lipid homeostasis and modulation of proteins and enzymes related to cholesterol influx and efflux, but not with the increase of cholesterol esterification. Lipid receptor expression, such as CD36 and FABP4, are also increased during macrophage infection by both pathogens, which can explain the augmented intake of free FAs or oxidized-LDL. These alterations in lipid metabolism are closely related to the formation of foamy macrophages and the occurrence of atherosclerosis and cardiovascular accidents (<xref ref-type="bibr" rid="B131">Kim et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B130">Rho et&#xa0;al., 2021</xref>).</p>
<p>Increased expression of the FA transporter CD36 is also observed in primary endothelial cell lines after infection by pathogenic leptospires, <italic>L. interrogans</italic> (<xref ref-type="bibr" rid="B31">Sato and Coburn, 2017</xref>). Interestingly, hamsters infected by pathogenic leptospires have circulating foamy macrophages (<xref ref-type="bibr" rid="B132">Putz et&#xa0;al., 2021</xref>). The occurrence of foamy macrophages is well described in mycobacterial infection, due to the accumulation of LDs in the cytoplasm of those phagocytes (<xref ref-type="bibr" rid="B19">Agarwal et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B133">Laval et&#xa0;al., 2021</xref>). We can speculate that this increase may lead to augmented uptake of FAs by the cells, and consequently accumulation of neutral lipids in the cytoplasm. However, the mechanism by which bacteria enhance CD36 and other surface lipid receptor expression is still not completely understood.</p>
<p>The interaction of pathogens with surface receptors and lipid rafts is necessary for adhesion, but also facilitates entrance into the cell, in the case of intracellular pathogens (<xref ref-type="bibr" rid="B16">van der Meer-Janssen et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B127">Crowley et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B135">Vromman and Subtil, 2014</xref>; <xref ref-type="bibr" rid="B116">Du et&#xa0;al., 2016</xref>). The close contact between host cells and bacteria also facilitates the interchange of phospholipids, as in the case of <italic>B. burgdorferi</italic> and <italic>H. pylori</italic> (<xref ref-type="bibr" rid="B105">Wunder et&#xa0;al., 2006</xref>; <xref ref-type="bibr" rid="B127">Crowley et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B116">Du et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B118">Qaria et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B129">Arora et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B128">Gwynne et&#xa0;al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="conclusions">
<label>4</label>
<title>Conclusions</title>
<p>Lipids and lipid metabolism are crucial for normal cell functioning, mainly in cells that rely only on &#x3b2;-oxidation as a source of ATP. Subversion of &#x3b2;-oxidation and of functioning of FAT, FABP, and FATP are used by pathogens to acquire free FAs as carbon sources, for energy, and production of other molecules.</p>
<p>Intracellular pathogens evolved mechanisms to exploit cell FA metabolism and membrane lipids to favor their growth and survival. The strategies to accomplish this fate are well reported in the literature, and there are plenty of studies describing the exact mechanism used by those pathogens.</p>
<p>Considering that extracellular bacteria lack the machinery for lipid metabolism and production of cholesterol, the exploitation of lipids from the host&#x2019;s cell membrane is used as the source of lipids that will compose the bacterial membrane. A close interaction between host cells and bacteria is needed to allow membrane lipids to interchange, and this interaction is mediated by lipid rafts present in both host cell and bacterial membrane.</p>
<p>To date, only a few works have been published addressing the use of lipids and the exploitation of lipid metabolism by extracellular pathogens. Those scarce, but relevant studies, however, shed light on the role of lipids in the interaction between extracellular pathogens and host cells, and point to the need for more experimental studies to uncover the pathways underlying these processes.</p>
</sec>
<sec id="s5" sec-type="author-contributions">
<title>Author contributions</title>
<p>LP wrote the manuscript and conceived the figure. NC and AB revised it critically for intellectual content. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="funding-information">
<title>Funding</title>
<p>We thank Funda&#xe7;&#xe3;o Butantan and Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo (FAPESP) for the funding, grant # 2021/01122-9, and the Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior (CAPES) for the scholarship granted to the first author, PROEX 88887.357170/2019-00.</p>
</sec>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdulova</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Purelku</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sahin</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Tanr&#x131;verdi</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Human ovarian granulosa cells use clathrin-mediated endocytosis for LDL uptake: immunocytochemical and electron microscopic study</article-title>. <source>Ultrastruct Pathol.</source> <volume>47</volume> (<issue>4</issue>), <fpage>241</fpage>&#x2013;<lpage>252</lpage>. doi: <pub-id pub-id-type="doi">10.1080/01913123.2023.2200532</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Accioly</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Pacheco</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Maya-Monteiro</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Carrossini</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Robbs</surname> <given-names>B. K.</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>S. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells</article-title>. <source>Cancer Res.</source> <volume>68</volume> (<issue>6</issue>), <fpage>1732</fpage>&#x2013;<lpage>1740</lpage>. doi: <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-1999</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adeva-Andany</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Carneiro-Freire</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Seco-Filgueira</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Fern&#xe1;ndez</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Mouri&#xf1;o-Bayolo</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Mitochondrial &#x3b2;-oxidation of saturated fatty acids in humans</article-title>. <source>Mitochondrion</source> <volume>46</volume>, <fpage>73</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mito.2018.02.009</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gordon</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>F. O.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Foam cell macrophages in tuberculosis</article-title>. <source>Front. Immunol.</source> <volume>12</volume> (<issue>775326</issue>). doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.775326</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname> <given-names>P. E.</given-names>
</name>
<name>
<surname>Roque</surname> <given-names>N. R.</given-names>
</name>
<name>
<surname>Magalh&#xe3;es</surname> <given-names>K. G.</given-names>
</name>
<name>
<surname>Mattos</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Teixeira</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Maya-Monteiro</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection</article-title>. <source>Biochim. Biophys. Acta Mol. Cell Biol. Lipids</source> <volume>1841</volume> (<issue>1</issue>), <fpage>97</fpage>&#x2013;<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbalip.2013.10.008</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambroggio</surname> <given-names>E. E.</given-names>
</name>
<name>
<surname>Navarro</surname> <given-names>G. S. C.</given-names>
</name>
<name>
<surname>Socas</surname> <given-names>L. B. P.</given-names>
</name>
<name>
<surname>Bagatolli</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Gamarnik</surname> <given-names>A. V.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Dengue and Zika virus capsid proteins bind to membranes and self-assemble into liquid droplets with nucleic acids</article-title>. <source>J. Biol. Chem.</source> <volume>297</volume> (<issue>3</issue>), <elocation-id>101059</elocation-id>. doi: <pub-id pub-id-type="doi">10.1016/j.jbc.2021.101059</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Interferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis</article-title>. <source>Front. Immunol.</source> <volume>13</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.1007718</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Stahl</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>SLC27 fatty acid transport proteins</article-title>. <source>Mol. Aspects Med.</source> <volume>34</volume> (<issue>2&#x2013;3</issue>), <fpage>516</fpage>&#x2013;<lpage>528</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mam.2012.07.010</pub-id>
</citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arora</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hart</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Fikrig</surname> <given-names>E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Use of host lipids by the Lyme disease spirochete may lead to biomarkers</article-title>. <source>J. Clin. Invest.</source> <volume>132</volume> (<issue>6</issue>), <elocation-id>e158254</elocation-id>. doi: <pub-id pub-id-type="doi">10.1172/JCI158254</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagayoko</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Leon-Icaza</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Pinilla</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hessel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Santoni</surname> <given-names>K.</given-names>
</name>
<name>
<surname>P&#xe9;ricat</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology</article-title>. <source>PLoS Pathog.</source> <volume>17</volume> (<issue>9</issue>), <elocation-id>e1009927</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1009927</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barba</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Harper</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Harada</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kohara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Goulinet</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Matsuura</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>94</volume> (<issue>4</issue>), <fpage>1200</fpage>&#x2013;<lpage>1205</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.94.4.1200</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barletta</surname> <given-names>A. B. F.</given-names>
</name>
<name>
<surname>Alves</surname> <given-names>L. R.</given-names>
</name>
<name>
<surname>Nascimento Silva</surname> <given-names>M. C. L.</given-names>
</name>
<name>
<surname>Sim</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Dimopoulos</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Liechocki</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Emerging role of lipid droplets in Aedes aEgypti immune response against bacteria and Dengue virus</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <elocation-id>19928</elocation-id>. doi: <pub-id pub-id-type="doi">10.1038/srep19928</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berndt</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Eckstein</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Heucke</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Gajowski</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Stockmann</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Meierhofer</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Characterization of lipid and lipid droplet metabolism in human HCC</article-title>. <source>Cells</source> <volume>8</volume> (<issue>5</issue>), <elocation-id>512</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/cells8050512</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bosch</surname> <given-names>M.</given-names>
</name>
<name>
<surname>S&#xe1;nchez-&#xc1;lvarez</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fajardo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Kapetanovic</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Steiner</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dutra</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense</article-title>. <source>Science</source> <volume>370</volume> (<issue>6514</issue>), <elocation-id>eaay8085</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/science.aay8085</pub-id>
</citation>
</ref>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cockcroft</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Mammalian lipids: structure, synthesis and function</article-title>. <source>Essays Biochem.</source> <volume>65</volume>, <fpage>813</fpage>&#x2013;<lpage>845</lpage>. doi: <pub-id pub-id-type="doi">10.1042/EBC20200067</pub-id>
</citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crowley</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Toledo</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Larocca</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Coleman</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>London</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Benach</surname> <given-names>J. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Lipid exchange between Borrelia burgdorferi and host cells</article-title>. <source>PLoS Pathog.</source> <volume>9</volume> (<issue>1</issue>), <elocation-id>e1003109</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1003109</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Da Mata Madeira</surname> <given-names>P. V.</given-names>
</name>
<name>
<surname>Zouhir</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Basso</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Laubier</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Salacha</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Structural basis of lipid targeting and destruction by the type V secretion system of Pseudomonas aeruginosa</article-title>. <source>J. Mol. Biol.</source> <volume>428</volume> (<issue>9 Pt A</issue>), <fpage>1790</fpage>&#x2013;<lpage>1803</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmb.2016.03.012</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva Gomes Dias</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>V. C.</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Sacramento</surname> <given-names>C. Q.</given-names>
</name>
<name>
<surname>Fintelman-Rodrigues</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Temerozo</surname> <given-names>J. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators</article-title>. <source>PLoS Pathog.</source> <volume>16</volume> (<issue>12</issue>), <elocation-id>e1009127</elocation-id>. doi: <pub-id pub-id-type="doi">10.1101/2020.08.22.262733</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#x2019;avila</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Melo</surname> <given-names>R. C. N.</given-names>
</name>
<name>
<surname>Parreira</surname> <given-names>G. G.</given-names>
</name>
<name>
<surname>Werneck-Barroso</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Castro-Faria-Neto</surname> <given-names>H. C.</given-names>
</name>
<name>
<surname>Bozza</surname> <given-names>P. T.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Mycobacterium bovis bacillus calmette-gu&#xe9;rin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis <italic>in vivo</italic> 1</article-title>. <source>J. Immunol.</source> <volume>176</volume>, <fpage>3087</fpage>&#x2013;<lpage>3097</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.176.5.3087</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deruelle</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Bouillot</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Job</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Taillebourg</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Fauvarque</surname> <given-names>M. O.</given-names>
</name>
<name>
<surname>Attr&#xe9;e</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The bacterial toxin ExoU requires a host trafficking chaperone for transportation and to induce necrosis</article-title>. <source>Nat. Commun.</source> <volume>12</volume> (<issue>1</issue>), <fpage>4024</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-24337-9</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname> <given-names>S. S. G.</given-names>
</name>
<name>
<surname>Cunha-Fernandes</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Souza-Moreira</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>V. C.</given-names>
</name>
<name>
<surname>Lima</surname> <given-names>G. B.</given-names>
</name>
<name>
<surname>Azevedo-Quintanilha</surname> <given-names>I. G.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Metabolic reprogramming and lipid droplets are involved in Zika virus replication in neural cells</article-title>. <source>J. Neuroinflamm.</source> <volume>20</volume> (<issue>1</issue>), <fpage>61</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12974-023-02736-7</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiRusso</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Darwis</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Watkins</surname> <given-names>P. A.</given-names>
</name>
<name>
<surname>Berger</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Black</surname> <given-names>P. N.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast</article-title>. <source>J. Biol. Chem.</source> <volume>280</volume> (<issue>17</issue>), <fpage>16829</fpage>&#x2013;<lpage>16837</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M409598200</pub-id>
</citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>H. H.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L. H. C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W. C.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Cholesterol glucosylation by Helicobacter pylori delays internalization and arrests phagosome maturation in macrophages</article-title>. <source>J. Microbiol. Immunol. Infect.</source> <volume>49</volume> (<issue>5</issue>), <fpage>636</fpage>&#x2013;<lpage>645</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmii.2014.05.011</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dulberger</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Rubin</surname> <given-names>E. J.</given-names>
</name>
<name>
<surname>Boutte</surname> <given-names>C. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The mycobacterial cell envelope - a moving target</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>18</volume> (<issue>1</issue>), <fpage>47</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41579-019-0273-7</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#xfc;vel</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Yecies</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Menon</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Raman</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Lipovsky</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>A. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Activation of a metabolic gene regulatory network downstream of mTOR complex 1</article-title>. <source>Mol. Cell</source> <volume>39</volume> (<issue>2</issue>), <fpage>171</fpage>&#x2013;<lpage>183</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2010.06.022</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Episcopio</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Aminov</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Benjamin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Germain</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Datan</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Landazuri</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus</article-title>. <source>FASEB J.</source> <volume>33</volume> (<issue>8</issue>), <fpage>9516</fpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.201900428RR</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Far&#xed;as</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Diethelm-Varela</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Navarro</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Kalergis</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname> <given-names>P. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Interplay between lipid metabolism, lipid droplets, and DNA virus infections</article-title>. <source>Cells</source> <volume>11</volume> (<issue>14</issue>), <elocation-id>2224</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/cells11142224</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frank</surname> <given-names>D. N.</given-names>
</name>
<name>
<surname>Bales</surname> <given-names>E. S.</given-names>
</name>
<name>
<surname>Monks</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jackman</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>MacLean</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Ir</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Perilipin-2 modulates lipid absorption and microbiome responses in the mouse intestine</article-title>. <source>PLoS One</source> <volume>10</volume> (<issue>7</issue>), <elocation-id>e0131944</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0131944</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freyre</surname> <given-names>C. A. C.</given-names>
</name>
<name>
<surname>Rauher</surname> <given-names>P. C.</given-names>
</name>
<name>
<surname>Ejsing</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Klemm</surname> <given-names>R. W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>MIGA2 Links Mitochondria, the ER, and lipid droplets and promotes <italic>de novo</italic> lipogenesis in adipocytes</article-title>. <source>Mol. Cell</source> <volume>76</volume> (<issue>5</issue>), <fpage>811</fpage>&#x2013;<lpage>825.e14</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molcel.2019.09.011</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furuhashi</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Fatty acid-binding protein 4 in cardiovascular and metabolic diseases</article-title>. <source>J. Atheroscler Thromb.</source> <volume>26</volume> (<issue>3</issue>), <fpage>216</fpage>&#x2013;<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.5551/jat.48710</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gago</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Diacovich</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Gramajo</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Lipid metabolism and its implication in mycobacteria&#x2013;host interaction</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>41</volume>, <fpage>36</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2017.11.020</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garc&#xed;a-Arcos</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez-Kother</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Aspichueta</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Rueda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ochoa</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Fresnedo</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Lipid analysis reveals quiescent and regenerating liver-specific populations of lipid droplets</article-title>. <source>Lipids</source> <volume>45</volume> (<issue>12</issue>), <fpage>1101</fpage>&#x2013;<lpage>1108</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11745-010-3492-2</pub-id>
</citation>
</ref>
<ref id="B120">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geisse</surname> <given-names>N. A.</given-names>
</name>
<name>
<surname>Cover</surname> <given-names>T. L.</given-names>
</name>
<name>
<surname>Henderson</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Edwardson</surname> <given-names>J. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analyzed by atomic force microscopy</article-title>. <source>Biochem. J.</source> <volume>381</volume>, <fpage>911</fpage>&#x2013;<lpage>917</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BJ20031719</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gewin</surname> <given-names>L. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Sugar or fat? Renal tubular metabolism reviewed in health and disease</article-title>. <source>Nutrients</source> <volume>13</volume> (<issue>5</issue>), <fpage>1580</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu13051580</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gorbenko</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Panayotou</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zhyvoloup</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Volkova</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Gout</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Filonenko</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4</article-title>. <source>Mol. Cell Biochem.</source> <volume>337</volume> (<issue>1&#x2013;2</issue>), <fpage>299</fpage>&#x2013;<lpage>305</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11010-009-0312-1</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenberg</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Egan</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Wek</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Garty</surname> <given-names>N. B.</given-names>
</name>
<name>
<surname>Joan Blanchette-Mackieej</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Londos</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets*</article-title>. <source>J. Of Biol. Chem.</source> <volume>266</volume> (<issue>17</issue>), <fpage>11341</fpage>&#x2013;<lpage>11346</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(18)99168-4</pub-id>
</citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname> <given-names>V. R.</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>H. K.</given-names>
</name>
<name>
<surname>Kostolansky</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Ballivian</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Eichberg</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Blanke</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA</article-title>. <source>PloS Pathog.</source> <volume>4</volume> (<issue>5</issue>), <elocation-id>e1000073</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1000073</pub-id>
</citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname> <given-names>V. R.</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>Blanke</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Sphingomyelin is important for the cellular entry and intracellular localization of Helicobacter pylori VacA</article-title>. <source>Cell Microbiol.</source> <volume>12</volume> (<issue>10</issue>), <fpage>1517</fpage>&#x2013;<lpage>1533</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1462-5822.2010.01487.x</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guyard</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Monteiro-Cardoso</surname> <given-names>V. F.</given-names>
</name>
<name>
<surname>Omrane</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sauvanet</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Houcine</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Boulogne</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>ORP5 and ORP8 orchestrate lipid droplet biogenesis and maintenance at ER&#x2013;mitochondria contact sites</article-title>. <source>J. Cell Biol.</source> <volume>221</volume> (<issue>9</issue>), <elocation-id>e202112107</elocation-id>. doi: <pub-id pub-id-type="doi">10.1083/jcb.202112107</pub-id>
</citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gwynne</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Clendenen</surname> <given-names>L. H.</given-names>
</name>
<name>
<surname>Turk</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Marques</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>L. T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Antiphospholipid autoantibodies in Lyme disease arise after scavenging of host phospholipids by Borrelia burgdorferi</article-title>. <source>J. Clin. Invest.</source> <volume>132</volume> (<issue>6</issue>), <elocation-id>e152506</elocation-id>. doi: <pub-id pub-id-type="doi">10.1172/JCI152506</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1</article-title>. <source>Nature</source> <volume>524</volume> (<issue>7564</issue>), <fpage>243</fpage>&#x2013;<lpage>246</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature14557</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helbig</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Carr</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Calvert</surname> <given-names>J. K.</given-names>
</name>
<name>
<surname>Wati</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Eyre</surname> <given-names>N. S.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>7</volume> (<issue>4</issue>), <elocation-id>e2178</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0002178</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Du</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>CD36 is involved in high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>468</volume> (<issue>1&#x2013;2</issue>), <fpage>281</fpage>&#x2013;<lpage>286</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.10.112</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsieh</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>Y. K.</given-names>
</name>
<name>
<surname>Londos</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Raaka</surname> <given-names>B. M.</given-names>
</name>
<name>
<surname>Dalen</surname> <given-names>K. T.</given-names>
</name>
<name>
<surname>Kimmel</surname> <given-names>A. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-esterspecific intracellular lipid storage droplets</article-title>. <source>J. Cell Sci.</source> <volume>125</volume> (<issue>17</issue>), <fpage>4067</fpage>&#x2013;<lpage>4076</lpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.104943</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fatuzzo</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Weng</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Michno</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Kienle</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Carnitine octanoyltransferase is important for the assimilation of exogenous acetyl-L-carnitine into acetyl-CoA in mammalian cells</article-title>. <source>J. Biol. Chem.</source> <volume>299</volume> (<issue>2</issue>), <elocation-id>102848</elocation-id>. doi: <pub-id pub-id-type="doi">10.1016/j.jbc.2022.102848</pub-id>
</citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname> <given-names>C. Y.</given-names>
</name>
<name>
<surname>Yeh</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C. Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H. Y.</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>C. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Helicobacter pylori cholesterol-&#x3b1;-glucosyltransferase manipulates cholesterol for bacterial adherence to gastric epithelial cells</article-title>. <source>Virulence</source> <volume>12</volume> (<issue>1</issue>), <fpage>2341</fpage>&#x2013;<lpage>2351</lpage>. doi: <pub-id pub-id-type="doi">10.1080/21505594.2021.1969171</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hua</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>H. Z.</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>L. T.</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Gui</surname> <given-names>H. B.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress</article-title>. <source>PLoS One</source> <volume>10</volume> (<issue>5</issue>), <elocation-id>e0127507</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0127507</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jansen</surname> <given-names>G. A.</given-names>
</name>
<name>
<surname>Wanders</surname> <given-names>R. J. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Alpha-oxidation</article-title>. <source>Biochim. Biophys. Acta Mol. Cell Res.</source> <volume>1763</volume> (<issue>12</issue>), <fpage>1403</fpage>&#x2013;<lpage>1412</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamcr.2006.07.012</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarc</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Petan</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Lipid droplets and the management of cellular stress</article-title>. <source>Yale J. Biol. Med.</source> <volume>92</volume> (<issue>3</issue>), <fpage>435</fpage>&#x2013;<lpage>452</lpage>.</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jay</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Hamilton</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL</article-title>. <source>Prostaglandins Leukot. Essent. Fatty Acids</source> <volume>138</volume>, <fpage>64</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.plefa.2016.05.005</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johannes</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wunder</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Shafaq-Zadah</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Glycolipids and lectins in endocytic uptake processes</article-title>. <source>J. Mol. Biol.</source> <volume>428</volume>, <fpage>4792</fpage>&#x2013;<lpage>4818</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmb.2016.10.027</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaksonen</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Roux</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mechanisms of clathrin-mediated endocytosis</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>19</volume>, <fpage>313</fpage>&#x2013;<lpage>326</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm.2017.132</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamili</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Roslan</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Frost</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cantrill</surname> <given-names>L. C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Della-Franca</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>TPD52 expression increases neutral lipid storage within cultured cells</article-title>. <source>J. Cell Sci.</source> <volume>128</volume> (<issue>17</issue>), <fpage>3223</fpage>&#x2013;<lpage>3238</lpage>. doi: <pub-id pub-id-type="doi">10.1242/jcs.167692</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>H. M.</given-names>
</name>
<name>
<surname>Ahn</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>Y. A.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Chinga</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development</article-title>. <source>Nat. Med.</source> <volume>21</volume> (<issue>1</issue>), <fpage>37</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm.3762</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiarely Souza</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Pereira-Dutra</surname> <given-names>F. S.</given-names>
</name>
<name>
<surname>Raj&#xe3;o</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Ferraro-Moreira</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Goltara-Gomes</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Cunha-Fernandes</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Lipid droplet accumulation occurs early following Salmonella infection and contributes to intracellular bacterial survival and replication</article-title>. <source>Mol. Microbiol.</source> <volume>117</volume> (<issue>2</issue>), <fpage>293</fpage>&#x2013;<lpage>306</lpage>. doi: <pub-id pub-id-type="doi">10.1111/mmi.14844</pub-id>
</citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>I. J.</given-names>
</name>
<name>
<surname>Blanke</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Remodeling the host environment: modulation of the gastric epithelium by the Helicobacter pylori vacuolating toxin (VacA</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>2</volume>, <elocation-id>37</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcimb.2012.00037</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Farese</surname> <given-names>R. V.</given-names>
</name>
<name>
<surname>Walther</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Voth</surname> <given-names>G. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Key factors governing initial stages of lipid droplet formation</article-title>. <source>J. Phys. Chem. B</source> <volume>126</volume> (<issue>2</issue>), <fpage>453</fpage>&#x2013;<lpage>462</lpage>. doi: <pub-id pub-id-type="doi">10.1021/acs.jpcb.1c09683</pub-id>
</citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Rho</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Woo</surname> <given-names>B. H.</given-names>
</name>
<name>
<surname>Joo</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Periodontal pathogens modulate lipid flux <italic>via</italic> fatty acid binding protein 4</article-title>. <source>J. Dent. Res.</source> <volume>98</volume> (<issue>13</issue>), <fpage>1511</fpage>&#x2013;<lpage>1520</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0022034519880824</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knight</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Braverman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Asfaha</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Gronert</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Stanley</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-&#x3b3;/HIF-1&#x3b1; signaling and supports host defense</article-title>. <source>PloS Pathog.</source> <volume>14</volume> (<issue>1</issue>), <elocation-id>e1006874</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1006874</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Inoguchi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Maeda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nakashima</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kuwano</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Eto</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets</article-title>. <source>J. Clin. Endocrinol. Metab.</source> <volume>93</volume> (<issue>7</issue>), <fpage>2877</fpage>&#x2013;<lpage>2884</lpage>. doi: <pub-id pub-id-type="doi">10.1210/jc.2007-2247</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostarnoy</surname> <given-names>A. V.</given-names>
</name>
<name>
<surname>Gancheva</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Kireev</surname> <given-names>I. I.</given-names>
</name>
<name>
<surname>Soloviev</surname> <given-names>A. I.</given-names>
</name>
<name>
<surname>Lepenies</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Kulibin</surname> <given-names>A. Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>A mechanism of self-lipid endocytosis mediated by the receptor Mincle</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>119</volume> (<issue>30</issue>), <elocation-id>e2120489119</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuerschner</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Moessinger</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Thiele</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Imaging of lipid biosynthesis: How a neutral lipid enters lipid droplets</article-title>. <source>Traffic</source> <volume>9</volume> (<issue>3</issue>), <fpage>338</fpage>&#x2013;<lpage>352</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1600-0854.2007.00689.x</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Majumder</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Mal</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Jana</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Activating transcription factor 3 modulates the macrophage immune response to Mycobacterium tuberculosis infection via reciprocal regulation of inflammatory genes and lipid body formation</article-title>. <source>Cell Microbiol.</source> <volume>22</volume> (<issue>3</issue>), <elocation-id>e13142</elocation-id>. doi: <pub-id pub-id-type="doi">10.1111/cmi.13142</pub-id>
</citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laval</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Chaumont</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Demangel</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis</article-title>. <source>Immunol. Rev.</source> <volume>301</volume> (<issue>1</issue>), <fpage>84</fpage>&#x2013;<lpage>97</lpage>. doi: <pub-id pub-id-type="doi">10.1111/imr.12952</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>England</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Dempsey</surname> <given-names>J. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Post-transcriptional regulation of <italic>de novo</italic> lipogenesis by mTORC1-S6K1-SRPK2 signaling</article-title>. <source>Cell</source> <volume>171</volume> (<issue>7</issue>), <fpage>1545</fpage>&#x2013;<lpage>1558.e18</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2017.10.037</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Goldstein</surname> <given-names>J. L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>107</volume> (<issue>8</issue>), <fpage>3441</fpage>&#x2013;<lpage>3446</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0914798107</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sauter</surname> <given-names>E. R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>SnapShot: FABP functions</article-title>. <source>Cell</source> <volume>182</volume> (<issue>4</issue>), <fpage>1066</fpage>&#x2013;<lpage>1066</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2020.07.027</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J. Z.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Shan</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Storage lipid synthesis is necessary for autophagy induced by nitrogen starvation</article-title>. <source>FEBS Lett.</source> <volume>589</volume> (<issue>2</issue>), <fpage>269</fpage>&#x2013;<lpage>276</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.febslet.2014.11.050</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Libbing</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>McDevitt</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Azcueta</surname> <given-names>R. M. P.</given-names>
</name>
<name>
<surname>Ahila</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mulye</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Lipid droplets: A significant but understudied contributor of host<sup>&#x2013;</sup>bacterial interactions</article-title>. <source>Cells</source> <volume>8</volume> (<issue>4</issue>), <elocation-id>354</elocation-id>. doi: <pub-id pub-id-type="doi">10.3390/cells8040354</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Moktan</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Arrese</surname> <given-names>E. L.</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Membrane attachment and structure models of lipid storage droplet protein 1</article-title>. <source>Biochim. Biophys. Acta Biomembr</source> <volume>1838</volume> (<issue>3</issue>), <fpage>874</fpage>&#x2013;<lpage>881</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbamem.2013.12.003</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Cell entry of Bovine herpesvirus-1 through clathrin- and caveolin-mediated endocytosis requires activation of PI3K-Akt-NF-&#x3ba;B and Ras-p38 MAPK pathways as well as the interaction of BoHV-1 gD with cellular receptor nectin-1</article-title>. <source>Vet. Microbiol.</source> <volume>279</volume>, <elocation-id>109672</elocation-id>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2023.109672</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luiken</surname> <given-names>J. J. F. P.</given-names>
</name>
<name>
<surname>Bonen</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Glatz</surname> <given-names>J. F. C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Cellular fatty acid uptake is acutely regulated by membrane-associated fatty acid-binding proteins</article-title>. <source>Prostaglandins Leukot. Essent. Fatty Acids</source> <volume>67</volume> (<issue>2&#x2013;3</issue>), <fpage>73</fpage>&#x2013;<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1054/plef.2002.0401</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mannaerts</surname> <given-names>G. P.</given-names>
</name>
<name>
<surname>Van Veldhoven</surname> <given-names>P. P.</given-names>
</name>
<name>
<surname>Casteels</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Peroxisomal lipid degradation <italic>via</italic> &#x3b2;- and &#x3b1;-oxidation in mammals</article-title>. <source>Cell Biochem. Biophys.</source> <volume>32</volume> (<issue>1</issue>), <fpage>73</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1385/CBB:32:1-3:73</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mar&#xe9;chal</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Laviolette</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Rodrigue-Way</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sow</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Brochu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Caron</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The CD36-PPAR&#x3b3; Pathway in metabolic disorders</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume> (<issue>5</issue>), <fpage>1529</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms19051529</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markgraf</surname> <given-names>D. F.</given-names>
</name>
<name>
<surname>Klemm</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Junker</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hannibal-Bach</surname> <given-names>H. K.</given-names>
</name>
<name>
<surname>Ejsing</surname> <given-names>C. S.</given-names>
</name>
<name>
<surname>Rapoport</surname> <given-names>T. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>An ER protein functionally couples neutral lipid metabolism on lipid droplets to membrane lipid synthesis in the ER</article-title>. <source>Cell Rep.</source> <volume>6</volume> (<issue>1</issue>), <fpage>44</fpage>&#x2013;<lpage>55</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2013.11.046</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melton</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Cerny</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Dirusso</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Black</surname> <given-names>P. N.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>440</volume> (<issue>4</issue>), <fpage>743</fpage>&#x2013;<lpage>748</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.09.137</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monson</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Crosse</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W.</given-names>
</name>
<name>
<surname>O&#x2019;Shea</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Wakim</surname> <given-names>L. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>a). <article-title>Intracellular lipid droplet accumulation occurs early following viral infection and is required for an efficient interferon response</article-title>. <source>Nat. Commun.</source> <volume>12</volume> (<issue>1</issue>), <elocation-id>4303</elocation-id>. doi: <pub-id pub-id-type="doi">10.1038/s41467-021-24632-5</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monson</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Trenerry</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Laws</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>MacKenzie</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Helbig</surname> <given-names>K. J.</given-names>
</name>
</person-group> (<year>2021</year>b). <article-title>Lipid droplets and lipid mediators in viral infection and immunity</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>45</volume> (<issue>4</issue>), <fpage>1</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1093/femsre/fuaa066</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreira</surname> <given-names>L. S.</given-names>
</name>
<name>
<surname>Piva</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Gentile</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Mesquita-Santos</surname> <given-names>F. P.</given-names>
</name>
<name>
<surname>D&#x2019;Avila</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Maya-Monteiro</surname> <given-names>C. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells</article-title>. <source>Biochim. Biophys. Acta Mol. Cell Biol. Lipids</source> <volume>1791</volume> (<issue>3</issue>), <fpage>156</fpage>&#x2013;<lpage>165</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbalip.2009.01.003</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Najt</surname> <given-names>C. P.</given-names>
</name>
<name>
<surname>Devarajan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mashek</surname> <given-names>D. G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Perilipins at a glance</article-title>. <source>J. Cell Sci.</source> <volume>135</volume> (<issue>5</issue>), <elocation-id>jcs259501</elocation-id>. doi: <pub-id pub-id-type="doi">10.1242/jcs.259501</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Febbraio</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Silversterin</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Hajjar</surname> <given-names>D. P.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis</article-title>. <source>Ann. N Y Acad. Sci.</source> <volume>947</volume>, <fpage>224</fpage>&#x2013;<lpage>228</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1749-6632.2001.tb03944.x</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nose</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Yamaguchi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kato</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Aiuchi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Obama</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Hara</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Crucial role of perilipin-3 (TIP47) in formation of lipid droplets and PGE2 production in HL-60-derived neutrophils</article-title>. <source>PloS One</source> <volume>8</volume> (<issue>8</issue>), <elocation-id>e71542</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0071542</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oluwadare</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cabodevilla</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Son</surname> <given-names>N. H.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Mullick</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Verano</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Blocking lipid uptake pathways does not prevent toxicity in adipose triglyceride lipase (ATGL) deficiency</article-title>. <source>J. Lipid Res.</source> <volume>63</volume> (<issue>11</issue>), <elocation-id>100274</elocation-id>. doi: <pub-id pub-id-type="doi">10.1016/j.jlr.2022.100274</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ono</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Studies of the FABP family: A retrospective</article-title>. <source>Mol. Cell Biochem.</source> <volume>277</volume> (<issue>1&#x2013;2</issue>), <fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11010-005-4816-z</pub-id>
</citation>
</ref>
<ref id="B126">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xd6;stberg</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Berg</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Comstedt</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wieslander</surname> <given-names>&#xc5;</given-names>
</name>
<name>
<surname>Bergstr&#xf6;m</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Functional analysis of a lipid galactosyltransferase synthesizing the major envelope lipid in the Lyme disease spirochete Borrelia burgdorferi</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>272</volume> (<issue>1</issue>), <fpage>22</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1574-6968.2007.00728.x</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owen</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Farooqi</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Hammer</surname> <given-names>R. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>109</volume> (<issue>40</issue>), <fpage>16184</fpage>&#x2013;<lpage>16189</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1213343109</pub-id>
</citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagliaccia</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X. M.</given-names>
</name>
<name>
<surname>Tardy</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Telford</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Ruysschaert</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Cabiaux</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Structure and interaction of VacA of Helicobacter pylori with a lipid membrane</article-title>. <source>Eur. J. Biochem.</source> <volume>267</volume> (<issue>1</issue>), <fpage>104</fpage>&#x2013;<lpage>109</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.00970.x</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pe&#xf1;a C&#xe1;rcamo</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Morell</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>V&#xe1;zquez</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Vatansever</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Upadhyay</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>&#xd6;verby</surname> <given-names>A. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The interplay between viperin antiviral activity, lipid droplets and Jun&#xed;n mammarenavirus multiplication</article-title>. <source>Virology</source> <volume>514</volume>, <fpage>216</fpage>&#x2013;<lpage>229</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.virol.2017.10.012</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pepino</surname> <given-names>M. Y.</given-names>
</name>
<name>
<surname>Kuda</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Samovski</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Abumrad</surname> <given-names>N. A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism</article-title>. <source>Annu. Rev. Nutr.</source> <volume>34</volume>, <fpage>281</fpage>&#x2013;<lpage>303</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-nutr-071812-161220</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname> <given-names>T. R.</given-names>
</name>
<name>
<surname>Sengupta</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>T. E.</given-names>
</name>
<name>
<surname>Carmack</surname> <given-names>A. E.</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Balderas</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>MTOR complex 1 regulates lipin 1 localization to control the srebp pathway</article-title>. <source>Cell</source> <volume>146</volume> (<issue>3</issue>), <fpage>408</fpage>&#x2013;<lpage>420</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2011.06.034</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plotkowski</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Brand&#xe3;o</surname> <given-names>B. A.</given-names>
</name>
<name>
<surname>de Assis</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Feliciano</surname> <given-names>L. F. P.</given-names>
</name>
<name>
<surname>Raymond</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Freitas</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells</article-title>. <source>Microb. Pathog.</source> <volume>45</volume> (<issue>1</issue>), <fpage>30</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.micpath.2008.01.008</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pombinho</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Sousa</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cabanes</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Scavenger receptors: promiscuous players during microbial pathogenesis</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>44</volume> (<issue>6</issue>), <fpage>685</fpage>&#x2013;<lpage>700</lpage>. doi: <pub-id pub-id-type="doi">10.1080/1040841X.2018.1493716</pub-id>
</citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Putz</surname> <given-names>E. J.</given-names>
</name>
<name>
<surname>Andreasen</surname> <given-names>C. B.</given-names>
</name>
<name>
<surname>Stasko</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Fernandes</surname> <given-names>L. G. V.</given-names>
</name>
<name>
<surname>Palmer</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Rauh</surname> <given-names>M. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Circulating foamy macrophages in the golden Syrian hamster (Mesocricetus auratus) model of leptospirosis</article-title>. <source>J. Comp. Pathol.</source> <volume>189</volume>, <fpage>98</fpage>&#x2013;<lpage>109</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcpa.2021.10.004</pub-id>
</citation>
</ref>
<ref id="B118">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qaria</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Qumar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sepe</surname> <given-names>L. P.</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cholesterol glucosylation-based survival strategy in Helicobacter pylori</article-title>. <source>Helicobacter</source> <volume>26</volume> (<issue>2</issue>), <elocation-id>e12777</elocation-id>. doi: <pub-id pub-id-type="doi">10.1111/hel.12777</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sheng</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Effects of saturated long-chain fatty acid on mRNA expression of genes associated with milk fat and protein biosynthesis in bovine mammary epithelial cells</article-title>. <source>Asian-Australas J. Anim. Sci.</source> <volume>27</volume> (<issue>3</issue>), <fpage>414</fpage>&#x2013;<lpage>421</lpage>. doi: <pub-id pub-id-type="doi">10.5713/ajas.2013.13499</pub-id>
</citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raghunathan</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Foegeding</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Cover</surname> <given-names>T. L.</given-names>
</name>
<name>
<surname>Ohi</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Kenworthy</surname> <given-names>A. K.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Determinants of raft partitioning of the helicobacter pylori pore-forming toxin vacA</article-title>. <source>Infect Immun</source> <volume>86</volume> (<issue>5</issue>), <elocation-id>e00872-17</elocation-id>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00872-17</pub-id>
</citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rho</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Joo</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>H. R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Periodontal pathogens promote foam cell formation by blocking lipid efflux</article-title>. <source>J. Dent. Res.</source> <volume>100</volume> (<issue>12</issue>), <fpage>1367</fpage>&#x2013;<lpage>1377</lpage>. doi: <pub-id pub-id-type="doi">10.1177/00220345211008811</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saliba</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Nascimento</surname> <given-names>D. O.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>M. C. A.</given-names>
</name>
<name>
<surname>Assis</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Gayer</surname> <given-names>C. R. M.</given-names>
</name>
<name>
<surname>Raymond</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Eicosanoid-mediated proinflammatory activity of pseudomonas aeruginosa ExoU</article-title>. <source>Cell Microbiol.</source> <volume>7</volume> (<issue>12</issue>), <fpage>1811</fpage>&#x2013;<lpage>1822</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00635.x</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samsa</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Mondotte</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Iglesias</surname> <given-names>N. G.</given-names>
</name>
<name>
<surname>Assun&#xe7;&#xe3;o-Miranda</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Barbosa-Lima</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Da Poian</surname> <given-names>A. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Dengue virus capsid protein usurps lipid droplets for viral particle formation</article-title>. <source>PLoS Pathog.</source> <volume>5</volume> (<issue>10</issue>), <elocation-id>e1000632</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1000632</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Coburn</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Leptospira interrogans causes quantitative and morphological disturbances in adherens junctions and other biological groups of proteins in human endothelial cells</article-title>. <source>PLoS Negl. Trop. Dis.</source> <volume>11</volume> (<issue>7</issue>), <fpage>1</fpage>&#x2013;<lpage>27</lpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0005830</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schoeler</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Caesar</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Dietary lipids, gut microbiota and lipid metabolism</article-title>. <source>Rev. Endocr. Metab. Disord.</source> <volume>20</volume> (<issue>4</issue>), <fpage>461</fpage>&#x2013;<lpage>472</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11154-019-09512-0</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xfc;tter</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Giavalisco</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Brodesser</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Graef</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Local Fatty Acid Channeling into Phospholipid Synthesis Drives Phagophore Expansion during Autophagy</article-title>. <source>Cell</source> <volume>180</volume> (<issue>1</issue>), <fpage>135</fpage>&#x2013;<lpage>149.e14</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2019.12.005</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwenk</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Holloway</surname> <given-names>G. P.</given-names>
</name>
<name>
<surname>Luiken</surname> <given-names>J. J. F. P.</given-names>
</name>
<name>
<surname>Bonen</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Glatz</surname> <given-names>J. F. C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Fatty acid transport across the cell membrane: regulation by fatty acid transporters</article-title>. <source>Prostaglandins Leukot. Essent. Fatty Acids</source> <volume>82</volume> (<issue>4&#x2013;6</issue>), <fpage>149</fpage>&#x2013;<lpage>154</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.plefa.2010.02.029</pub-id>
</citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sewald</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Haas</surname> <given-names>R</given-names>
</name>
</person-group>. (<year>2008</year>). <article-title>Sticky socks: Helicobacter pylori VacA takes shape</article-title>. <source>Trends in Microbiol</source> <volume>16</volume> (<issue>3</issue>), <fpage>89</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2008.01.001</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Faridi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Mir</surname> <given-names>I. A.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S. K.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Characterization of exo-s, exo-u, and alg virulence factors and antimicrobial resistance in Pseudomonas aeruginosa isolated from migratory Egyptian vultures from India</article-title>. <source>Infect. Ecol. Epidemiol.</source> <volume>4</volume> (<issue>1</issue>), <fpage>24553</fpage>. doi: <pub-id pub-id-type="doi">10.3402/iee.v4.24553</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silverstein</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Febbraio</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior NIH public access</article-title>. <source>Sci. Signal</source> <volume>2</volume> (<issue>72</issue>), <elocation-id>re3</elocation-id>. doi: <pub-id pub-id-type="doi">10.1126/scisignal.272re3</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kaushik</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Novak</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Komatsu</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Autophagy regulates lipid metabolism</article-title>. <source>Nature</source> <volume>458</volume> (<issue>7242</issue>), <fpage>1131</fpage>&#x2013;<lpage>1135</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature07976</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Springer</surname> <given-names>T. I.</given-names>
</name>
<name>
<surname>Reid</surname> <given-names>T. E.</given-names>
</name>
<name>
<surname>Gies</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Feix</surname> <given-names>J. B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Interactions of the effector ExoU from pseudomonas aeruginosa with short-chain phosphatidylinositides provide insights into ExoU targeting to host membranes</article-title>. <source>J. Biol. Chem.</source> <volume>294</volume> (<issue>50</issue>), <fpage>19012</fpage>&#x2013;<lpage>19021</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.RA119.010278</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Storch</surname> <given-names>J.</given-names>
</name>
<name>
<surname>McDermott</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Structural and functional analysis of fatty acid-binding proteins</article-title>. <source>J. Lipid Res.</source> <volume>50</volume> (<supplement>SUPPL.</supplement>), <fpage>S126</fpage>&#x2013;<lpage>S131</lpage>. doi: <pub-id pub-id-type="doi">10.1194/jlr.R800084-JLR200</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stoyanova</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Jabeen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Landazuri Vinueza</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ghosh Roy</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lockshin</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Zakeri</surname> <given-names>Z.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Zika virus triggers autophagy to exploit host lipid metabolism and drive viral replication</article-title>. <source>Cell Communication Signaling</source> <volume>21</volume> (<issue>1</issue>), <fpage>114</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12964-022-01026-8</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subedi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Vijay</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Kohli</surname> <given-names>G. S.</given-names>
</name>
<name>
<surname>Rice</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Willcox</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Association between possession of ExoU and antibiotic resistance in pseudomonas aeruginosa</article-title>. <source>PloS One</source> <volume>13</volume> (<issue>9</issue>), <elocation-id>e0204936</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0204936</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Cideb deficiency aggravates dextran sulfate sodium-induced ulcerative colitis in mice by exacerbating the oxidative burden in colonic mucosa</article-title>. <source>Inflammation Bowel Dis.</source> <volume>23</volume> (<issue>8</issue>), <fpage>1338</fpage>&#x2013;<lpage>1347</lpage>. doi: <pub-id pub-id-type="doi">10.1097/MIB.0000000000001196</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Niyazbekova</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>ORFV entry into host cells <italic>via</italic> clathrin-mediated endocytosis and macropinocytosis</article-title>. <source>Vet. Microbiol.</source> <volume>284</volume>, <fpage>109831</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2023.109831</pub-id>
</citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trunk</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Casasanta</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Yoo</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Slade</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Leo</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Comparison of type 5d autotransporter phospholipases demonstrates a correlation between high activity and intracellular pathogenic lifestyle</article-title>. <source>Biochem. J.</source> <volume>476</volume> (<issue>18</issue>), <fpage>2657</fpage>&#x2013;<lpage>2676</lpage>. doi: <pub-id pub-id-type="doi">10.1042/BCJ20190136</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turchetto-Zolet</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Maraschin</surname> <given-names>F. S.</given-names>
</name>
<name>
<surname>De Morais</surname> <given-names>G. L.</given-names>
</name>
<name>
<surname>Cagliari</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>C. M. B.</given-names>
</name>
<name>
<surname>Margis-Pinheiro</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Evolutionary view of acyl-CoA diacylglycerol acyltransferase (DGAT), a key enzyme in neutral lipid biosynthesis</article-title>. <source>BMC Evol. Biol.</source> <volume>11</volume> (<issue>1</issue>), <elocation-id>263</elocation-id>. doi: <pub-id pub-id-type="doi">10.1186/1471-2148-11-263</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Meer-Janssen</surname> <given-names>Y. P. M.</given-names>
</name>
<name>
<surname>van Galen</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Batenburg</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Helms</surname> <given-names>J. B.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome</article-title>. <source>Prog. Lipid Res.</source> <volume>49</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>26</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.plipres.2009.07.003</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Meer</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Voelker</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Feigenson</surname> <given-names>G. W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Membrane lipids: where they are and how they behave</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>9</volume> (<issue>2</issue>), <fpage>112</fpage>&#x2013;<lpage>124</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrm2330</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viktorova</surname> <given-names>E. G.</given-names>
</name>
<name>
<surname>Nchoutmboube</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Ford-Siltz</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Iverson</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Belov</surname> <given-names>G. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Phospholipid synthesis fueled by lipid droplets drives the structural development of poliovirus replication organelles</article-title>. <source>PloS Pathog.</source> <volume>14</volume> (<issue>8</issue>), <elocation-id>e1007280</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1007280</pub-id>
</citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vromman</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Subtil</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Exploitation of host lipids by bacteria</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>17</volume> (<issue>1</issue>), <fpage>38</fpage>&#x2013;<lpage>45</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mib.2013.11.003</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walenna</surname> <given-names>N. F.</given-names>
</name>
<name>
<surname>Kurihara</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chou</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ishii</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Soejima</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Itoh</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Chlamydia pneumoniae exploits adipocyte lipid chaperone FABP4 to facilitate fat mobilization and intracellular growth in murine adipocytes</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>495</volume> (<issue>1</issue>), <fpage>353</fpage>&#x2013;<lpage>359</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.11.005</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walpole</surname> <given-names>G. F. W.</given-names>
</name>
<name>
<surname>Grinstein</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Westman</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The role of lipids in host-pathogen interactions</article-title>. <source>IUBMB Life</source> <volume>70</volume> (<issue>5</issue>), <fpage>384</fpage>&#x2013;<lpage>392</lpage>. doi: <pub-id pub-id-type="doi">10.1002/iub.1737</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>W&#xe4;ltermann</surname> <given-names>M.</given-names>
</name>
<name>
<surname>St&#xf6;veken</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Steinb&#xfc;chel</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Key enzymes for biosynthesis of neutral lipid storage compounds in prokaryotes: Properties, function and occurrence of wax ester synthases/acyl-CoA:diacylglycerol acyltransferases</article-title>. <source>Biochimie</source> <volume>89</volume>, <fpage>230</fpage>&#x2013;<lpage>242</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biochi.2006.07.013</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walther</surname> <given-names>T. C.</given-names>
</name>
<name>
<surname>Farese</surname> <given-names>R. V.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Lipid droplets and cellular lipid metabolism</article-title>. <source>Annu. Rev. Biochem.</source> <volume>81</volume>, <fpage>687</fpage>&#x2013;<lpage>714</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-biochem-061009-102430</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>M. Z. X.</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Genetic variety of ORF3a shapes SARS-CoV-2 fitness through modulation of lipid droplet</article-title>. <source>J. Med. Virol.</source> <volume>95</volume> (<issue>3</issue>), <elocation-id>e28630</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/jmv.28630</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Tontonoz</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Phospholipid remodeling in physiology and disease</article-title>. <source>Annu. Rev. Physiol. Annu. Reviews;</source> <volume>81</volume>, <fpage>165</fpage>&#x2013;<lpage>188</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-physiol-020518-114444</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wunder</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Churin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Winau</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Warnecke</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Vieth</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lindner</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Cholesterol glucosylation promotes immune evasion by Helicobacter pylori</article-title>. <source>Nat. Med.</source> <volume>12</volume> (<issue>9</issue>), <fpage>1030</fpage>&#x2013;<lpage>1038</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm1480</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Autophagy activation contributes to lipid accumulation in tubular epithelial cells during kidney fibrosis</article-title>. <source>Cell Death Discovery</source> <volume>4</volume> (<issue>1</issue>), <fpage>2</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41420-018-0065-2</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Okamura</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Moorhead</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Varghese</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>CD36 in chronic kidney disease: novel insights and therapeutic opportunities</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>13</volume> (<issue>12</issue>), <fpage>769</fpage>&#x2013;<lpage>781</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrneph.2017.126</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yoshimura</surname> <given-names>S. H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Self-assembly of CIP4 drives actin-mediated asymmetric pit-closing in clathrin-mediated endocytosis</article-title>. <source>Nat. Commun. [Internet]</source> <volume>14</volume> (<issue>1</issue>), <fpage>4602</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-023-40390-y</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>Z. W.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>SARS-CoV-2 exploits host DGAT and ADRP for efficient replication</article-title>. <source>Cell Discovery</source> <volume>7</volume> (<issue>1</issue>), <fpage>100</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41421-021-00338-2</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>